阿瑪琳 AMRN 深 滬
已收盤 09-20 16:00:00 美东时间
0.5901
-0.008
-1.42%
華盛通- 最 高0.5966
- 今 開0.595
- 成交量 56.16万股
- 最 低 0.5851
- 昨 收 0.5986
- 總市值 2.43亿
- 52周最高 1.37
- 市盈率 靜 --
- 換手率 0.14%
- 52周最低 0.5701
- 委 比 67.76%
- 總股本 4.11亿
- 歷史最高 26.12
- 量 比 1.05
- 振 幅 1.92%
- 歷史最低 0.5701
- 每 手 1
- 風險率 0.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多新浪财经ESG：阿玛琳 路孚特（Refinitiv）ESG评级调升至C
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
09-02 07:02
Amarin shares are trading lower. The company reported Q2 financial results.
Amarin shares are trading lower. The company reported Q2 financial results.
08-01 02:28
Cantor Fitzgerald Reiterates Overweight on Amarin Corp
Cantor Fitzgerald analyst Louise Chen reiterates Amarin Corp (NASDAQ:AMRN) with a Overweight.
06-18 21:57
Amarin Corporation Plc's (NASDAQ:AMRN) Revenues Are Not Doing Enough For Some Investors
You may think that with a price-to-sales (or "P/S") ratio of 1.2x Amarin Corpor...
06-17 19:39
快讯 | 成分股阿玛琳（AMRN）收跌17.91%Summit Therapeutics Plc.、23Andme Holding Co.、Janux Therapeutics跌17.36%-11.75%Humacyte也跌9.50%；和黄医药（HCM）则收涨6.49% Twist Bioscience涨6.75%再鼎医药ADR（ZLAB）涨7.17%Agios Pharmaceuticals涨8.03%Olema也涨18.96%。
成分股阿玛琳（AMRN）收跌17.91%Summit Therapeutics Plc.、23Andme Holding Co.、Janux Therapeu...
06-05 05:33
Amarin falls on CEO exit and Vascepa coverage update
Shares of Amarin Corporation (NASDAQ:AMRN) sold off in the morning hours Tuesday after the company announced the resignation of its CEO, Patrick Holt, and a major commercial update regarding commercia...
06-04 23:10
Amarin Leadership Changes Amidst VASCEPA Coverage Challenge
An announcement from Amarin (AMRN) is now available. Patrick Holt has stepped d...
06-04 19:51
Amarin names Aaron Berg as CEO
Amarin (NASDAQ:AMRN) said it has appointed its executive vice president, Aaron Berg as CEO and president. The appointment comes after the resignation of Patrick Holt as CEO and president. Berg had joi...
06-04 19:39
纳斯达克生物科技指数收涨2.18%
成分股Ventyx Biosciences收涨25.13%领跑，Summit Therapeutics Plc.、Cabaletta Bio、Wave Lif...
05-02 04:53
Amarin’s Sell Rating Affirmed Amid US Market Challenges and Uncertain European Growth
Goldman Sachs analyst Paul Choi maintained a Sell rating on Amarin (AMRN – Rese...
05-01 22:25
